Arvinas (ARVN) Financials

$6.51 +0.04 (+0.62%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$6.50 -0.01 (-0.15%)

As of 05/23/2025 07:33 PM Eastern

Annual Income Statements for Arvinas

This table shows Arvinas' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-199	-367	-283
Consolidated Net Income / (Loss)	-199	-367	-283
Net Income / (Loss) Continuing Operations	-199	-367	-283
Total Pre-Tax Income	-198	-364	-251
Total Operating Income	-250	-402	-263
Total Gross Profit	263	79	131
Total Revenue	263	79	131
Operating Revenue	263	79	131
Total Cost of Revenue	0.00	0.00	0.00
Total Operating Expenses	514	480	395
Selling, General & Admin Expense	165	100	80
Research & Development Expense	348	380	315
Total Other Income / (Expense), net	52	38	12
Interest & Investment Income	55	39	12
Other Income / (Expense), net	-2.90	-1.20	0.20
Income Tax Expense	0.60	0.90	21
Other Gains / (Losses), net	0.00	-2.50	-11
Basic Earnings per Share	($2.77)	($6.62)	($5.31)
Weighted Average Basic Shares Outstanding	71.90M	55.50M	53.20M
Diluted Earnings per Share	($2.77)	($6.62)	($5.31)
Weighted Average Diluted Shares Outstanding	71.90M	55.50M	53.20M
Weighted Average Basic & Diluted Shares Outstanding	68.77M	68.08M	53.27M

This table shows Arvinas' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-54	-41	-35	-69	-158	-61	-66	-82	-83	-66
Consolidated Net Income / (Loss)	-45	-49	-35	-69	-155	-64	-67	-82	-83	-66
Net Income / (Loss) Continuing Operations	-45	-49	-35	-69	-155	-64	-67	-82	-83	-66
Total Pre-Tax Income	-45	-49	-35	-69	-153	-64	-66	-81	-69	-61
Total Operating Income	-58	-60	-49	-83	-165	-74	-75	-88	-75	-64
Total Gross Profit	59	102	77	25	-43	35	55	33	38	33
Total Revenue	59	102	77	25	-43	35	55	33	38	33
Total Operating Expenses	117	163	125	109	122	109	129	120	113	98
Selling, General & Admin Expense	34	76	31	24	27	23	26	25	15	20
Research & Development Expense	83	87	94	84	95	86	103	95	98	78
Total Other Income / (Expense), net	13	12	14	14	12	10	9.00	6.50	6.20	3.20
Interest & Investment Income	13	14	14	14	12	10	9.00	7.60	5.60	3.40
Other Income / (Expense), net	-0.20	-2.60	-0.10	0.00	-0.10	0.00	0.00	-1.10	0.60	-0.20
Income Tax Expense	-0.30	0.60	0.20	0.10	1.60	0.00	-0.30	-0.40	11	2.20
Basic Earnings per Share	($0.63)	($0.68)	($0.49)	($0.97)	($2.65)	($1.18)	($1.25)	($1.54)	($1.55)	($1.24)
Weighted Average Basic Shares Outstanding	71.90M	72.10M	71.90M	71.70M	55.50M	54.10M	53.40M	53.30M	53.20M	53.20M
Diluted Earnings per Share	($0.63)	($0.68)	($0.49)	($0.97)	($2.65)	($1.18)	($1.25)	($1.54)	($1.55)	($1.24)
Weighted Average Diluted Shares Outstanding	71.90M	72.10M	71.90M	71.70M	55.50M	54.10M	53.40M	53.30M	53.20M	53.20M
Weighted Average Basic & Diluted Shares Outstanding	68.77M	68.71M	68.65M	68.43M	68.08M	55.03M	53.49M	53.40M	53.27M	53.23M

This table details how cash moves in and out of Arvinas' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	-217	230	-26
Net Cash From Operating Activities	-259	-348	-274
Net Cash From Continuing Operating Activities	-259	-348	-274
Net Income / (Loss) Continuing Operations	-199	-367	-283
Consolidated Net Income / (Loss)	-199	-367	-283
Depreciation Expense	4.60	4.80	6.30
Amortization Expense	-15	-13	9.40
Non-Cash Adjustments To Reconcile Net Income	88	73	76
Changes in Operating Assets and Liabilities, net	-138	-44	-83
Net Cash From Investing Activities	35	204	243
Net Cash From Continuing Investing Activities	35	204	243
Purchase of Property, Plant & Equipment	-1.80	-2.90	-6.80
Purchase of Investments	-652	-956	-886
Sale of Property, Plant & Equipment	0.10	0.00	0.00
Sale and/or Maturity of Investments	689	1,163	1,136
Net Cash From Financing Activities	7.90	375	4.70
Net Cash From Continuing Financing Activities	7.90	375	4.70
Repayment of Debt	-0.40	0.00	0.00
Repurchase of Common Equity	0.00	-17	0.00
Issuance of Common Equity	8.30	392	4.70
Cash Income Taxes Paid	2.30	11	11

This table details how cash moves in and out of Arvinas' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	15	-75	67	-224	198	23	-40	49	-51	40
Net Cash From Operating Activities	-84	-128	50	-98	-83	-85	-89	-91	-71	-67
Net Cash From Continuing Operating Activities	-84	-128	50	-98	-83	-85	-89	-91	-71	-67
Net Income / (Loss) Continuing Operations	-45	-49	-35	-69	-155	-64	-67	-82	-83	-66
Consolidated Net Income / (Loss)	-45	-49	-35	-69	-155	-64	-67	-82	-83	-66
Depreciation Expense	1.10	1.10	1.20	1.20	1.20	1.20	1.20	1.20	1.70	1.60
Amortization Expense	-3.20	-3.50	-3.90	-4.60	-5.20	-3.60	-2.30	-2.30	0.10	1.70
Non-Cash Adjustments To Reconcile Net Income	23	27	19	19	18	16	17	21	20	19
Changes in Operating Assets and Liabilities, net	-60	-104	70	-43	58	-35	-38	-29	-10	-23
Net Cash From Investing Activities	99	51	13	-128	-54	70	49	139	19	106
Net Cash From Continuing Investing Activities	99	51	13	-128	-54	70	49	139	19	106
Purchase of Property, Plant & Equipment	-0.30	-0.70	-0.70	-0.10	-0.10	-1.10	-0.60	-1.10	-1.10	-2.20
Purchase of Investments	-51	-160	-193	-248	-291	-173	-317	-176	-184	-233
Sale and/or Maturity of Investments	151	212	206	120	237	245	366	315	205	341
Net Cash From Financing Activities	0.50	2.40	3.40	1.60	335	38	0.50	1.50	0.50	1.20
Net Cash From Continuing Financing Activities	0.50	2.40	3.40	1.60	335	38	0.50	1.50	0.50	1.20
Repayment of Debt	-0.10	-	-0.10	-0.20	-	-	-	0.00	-	-
Issuance of Common Equity	0.60	2.40	3.50	1.80	351	39	0.50	1.50	0.50	1.20
Cash Income Taxes Paid	0.70	0.10	0.30	1.20	2.00	0.10	9.00	0.00	3.00	8.10

This table presents Arvinas' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	1,091	1,305	1,269
Total Current Assets	1,067	1,280	1,240
Cash & Equivalents	101	312	81
Restricted Cash	0.00	5.50	5.50
Short-Term Investments	939	949	1,124
Accounts Receivable	14	7.20	8.00
Prepaid Expenses	14	6.50	21
Plant, Property, & Equipment, net	7.00	12	13
Total Noncurrent Assets	17	13	15
Other Noncurrent Operating Assets	17	13	15
Total Liabilities & Shareholders' Equity	1,091	1,305	1,269
Total Liabilities	530	645	704
Total Current Liabilities	230	257	295
Accounts Payable	72	92	75
Current Deferred Revenue	156	163	219
Other Current Liabilities	1.80	1.90	1.80
Total Noncurrent Liabilities	300	388	409
Long-Term Debt	0.60	0.80	1.00
Noncurrent Deferred Revenue	292	386	405
Other Noncurrent Operating Liabilities	7.30	0.50	2.70
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	562	660	565
Total Preferred & Common Equity	562	660	565
Preferred Stock	0.00	0.00	0.00
Total Common Equity	562	660	565
Common Stock	2,092	1,996	1,550
Retained Earnings	-1,532	-1,333	-965
Accumulated Other Comprehensive Income / (Loss)	1.00	-3.10	-19

This table presents Arvinas' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	1,167	1,280	1,213	1,058	1,084	1,176	1,335
Total Current Assets	1,150	1,257	1,190	1,033	1,057	1,148	1,305
Cash & Equivalents	85	155	88	114	91	130	133
Restricted Cash	0.00	5.50	5.50	5.50	5.50	5.50	5.50
Short-Term Investments	1,036	1,074	1,081	885	948	993	1,138
Accounts Receivable	15	10	7.10	21	4.80	4.70	6.80
Prepaid Expenses	13	13	8.40	8.40	7.60	15	22
Plant, Property, & Equipment, net	6.80	9.80	10	13	13	13	14
Total Noncurrent Assets	11	1.50	12	13	14	14	16
Other Noncurrent Operating Assets	11	1.50	12	13	14	14	16
Total Liabilities & Shareholders' Equity	1,167	1,280	1,213	1,058	1,084	1,176	1,335
Total Liabilities	581	679	603	601	620	665	713
Total Current Liabilities	276	347	241	317	307	283	245
Accounts Payable	76	78	76	91	75	66	50
Current Deferred Revenue	199	268	163	224	230	215	193
Other Current Liabilities	0.80	1.20	1.50	1.90	1.90	1.90	1.80
Total Noncurrent Liabilities	305	332	362	284	313	382	469
Long-Term Debt	0.60	0.70	0.70	0.80	0.90	0.90	1.00
Noncurrent Deferred Revenue	305	331	361	282	311	379	465
Other Noncurrent Operating Liabilities	0.10	0.20	0.40	1.10	1.60	2.10	3.10
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	586	600	610	457	464	511	622
Total Preferred & Common Equity	586	600	610	457	464	511	622
Preferred Stock	0.00	0.00	0.00	-	-	-	-
Total Common Equity	586	600	610	457	464	511	622
Common Stock	2,068	2,041	2,016	1,644	1,590	1,571	1,529
Retained Earnings	-1,487	-1,437	-1,402	-1,178	-1,114	-1,047	-883
Accumulated Other Comprehensive Income / (Loss)	4.10	-3.80	-4.40	-9.20	-12	-13	-25

This table displays calculated financial ratios and metrics derived from Arvinas' official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	235.54%	-40.26%	145.15%
EBITDA Growth	35.89%	-66.32%	-45.39%
EBIT Growth	37.15%	-53.12%	-41.47%
NOPAT Growth	37.68%	-52.55%	-39.70%
Net Income Growth	45.85%	-30.02%	-47.91%
EPS Growth	58.16%	-24.67%	-39.01%
Operating Cash Flow Growth	25.45%	-27.17%	-148.89%
Free Cash Flow Firm Growth	5.16%	-15.93%	-149.27%
Invested Capital Growth	21.23%	6.08%	12.48%
Revenue Q/Q Growth	63.50%	-50.78%	3.63%
EBITDA Q/Q Growth	29.25%	-30.61%	-15.13%
EBIT Q/Q Growth	29.73%	-29.03%	-12.01%
NOPAT Q/Q Growth	29.99%	-28.85%	-11.86%
Net Income Q/Q Growth	35.55%	-24.34%	-11.88%
EPS Q/Q Growth	42.17%	-19.93%	-11.32%
Operating Cash Flow Q/Q Growth	-0.39%	-3.54%	-14.92%
Free Cash Flow Firm Q/Q Growth	-16.38%	1.77%	-8.72%
Invested Capital Q/Q Growth	10.82%	-10.97%	1.35%
Profitability Metrics	-	-	-
Gross Margin	100.00%	100.00%	100.00%
EBITDA Margin	-100.11%	-523.95%	-188.20%
Operating Margin	-94.99%	-511.47%	-200.30%
EBIT Margin	-96.09%	-512.99%	-200.15%
Profit (Net Income) Margin	-75.51%	-467.90%	-214.99%
Tax Burden Percent	100.30%	100.93%	112.55%
Interest Burden Percent	78.35%	90.37%	95.44%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%
Return on Equity (ROE)	-32.56%	-59.97%	-41.96%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	-21.13%	-31.30%	-18.45%
Return on Assets (ROA)	-16.60%	-28.55%	-19.82%
Return on Common Equity (ROCE)	-32.56%	-59.97%	-41.96%
Return on Equity Simple (ROE_SIMPLE)	-35.41%	-55.65%	-50.01%
Net Operating Profit after Tax (NOPAT)	-175	-281	-184
NOPAT Margin	-66.49%	-358.03%	-140.21%
Net Nonoperating Expense Percent (NNEP)	-2.06%	-6.97%	-7.20%
Return On Investment Capital (ROIC_SIMPLE)	-31.15%	-42.53%	-32.56%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	62.79%	127.77%	60.58%
R&D to Revenue	132.19%	483.69%	239.73%
Operating Expenses to Revenue	194.99%	611.47%	300.30%
Earnings before Interest and Taxes (EBIT)	-253	-403	-263
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-264	-411	-247
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	2.35	3.43	3.22
Price to Tangible Book Value (P/TBV)	2.35	3.43	3.22
Price to Revenue (P/Rev)	5.00	28.85	13.86
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	1.06	12.73	4.65
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00
Financial Leverage	-1.89	-2.02	-2.03
Leverage Ratio	1.96	2.10	2.12
Compound Leverage Factor	1.54	1.90	2.02
Debt to Total Capital	0.11%	0.12%	0.18%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.11%	0.12%	0.18%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	99.89%	99.88%	99.82%
Debt to EBITDA	0.00	0.00	0.00
Net Debt to EBITDA	3.94	3.08	4.89
Long-Term Debt to EBITDA	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	-0.01
Net Debt to NOPAT	5.93	4.50	6.57
Long-Term Debt to NOPAT	0.00	0.00	-0.01
Altman Z-Score	-0.08	0.66	0.80
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	4.64	4.98	4.20
Quick Ratio	4.58	4.93	4.11
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-304	-320	-276
Operating Cash Flow to CapEx	-15,252.94%	-11,993.10%	-4,022.06%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	0.22	0.06	0.09
Accounts Receivable Turnover	25.21	10.33	7.80
Inventory Turnover	0.00	0.00	0.00
Fixed Asset Turnover	28.48	6.31	10.07
Accounts Payable Turnover	0.00	0.00	0.00
Days Sales Outstanding (DSO)	14.48	35.34	46.81
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	14.48	35.34	46.81
Capital & Investment Metrics	-	-	-
Invested Capital	-477	-606	-645
Invested Capital Turnover	-0.49	-0.13	-0.19
Increase / (Decrease) in Invested Capital	129	39	92
Enterprise Value (EV)	278	999	611
Market Capitalization	1,317	2,265	1,821
Book Value per Share	$8.17	$11.99	$10.61
Tangible Book Value per Share	$8.17	$11.99	$10.61
Total Capital	562	661	566
Total Debt	0.60	0.80	1.00
Total Long-Term Debt	0.60	0.80	1.00
Net Debt	-1,039	-1,266	-1,210
Capital Expenditures (CapEx)	1.70	2.90	6.80
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-202	-243	-266
Debt-free Net Working Capital (DFNWC)	838	1,023	945
Net Working Capital (NWC)	838	1,023	945
Net Nonoperating Expense (NNE)	24	86	98
Net Nonoperating Obligations (NNO)	-1,039	-1,266	-1,210
Total Depreciation and Amortization (D&A)	-11	-8.60	16
Debt-free, Cash-free Net Working Capital to Revenue	-76.65%	-310.06%	-202.21%
Debt-free Net Working Capital to Revenue	317.96%	1,303.31%	719.25%
Net Working Capital to Revenue	317.96%	1,303.31%	719.25%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($2.77)	($6.62)	($5.31)
Adjusted Weighted Average Basic Shares Outstanding	71.90M	55.50M	53.20M
Adjusted Diluted Earnings per Share	($2.77)	($6.62)	($5.31)
Adjusted Weighted Average Diluted Shares Outstanding	71.90M	55.50M	53.20M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	68.77M	68.08M	53.27M
Normalized Net Operating Profit after Tax (NOPAT)	-175	-281	-184
Normalized NOPAT Margin	-66.49%	-358.03%	-140.21%
Pre Tax Income Margin	-75.28%	-463.57%	-191.02%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-4.63%	0.00%

This table displays calculated financial ratios and metrics derived from Arvinas' official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	237.36%	195.95%	40.37%	-22.15%	-213.72%	4.22%	61.24%	22.64%	13.81%	256.99%
EBITDA Growth	64.34%	14.42%	32.23%	3.56%	-132.05%	-24.67%	-24.10%	-72.55%	-80.25%	-44.34%
EBIT Growth	64.75%	14.89%	34.85%	6.19%	-121.12%	-14.57%	-13.20%	-53.63%	-60.52%	-36.94%
NOPAT Growth	64.85%	18.40%	34.99%	5.02%	-119.23%	-14.93%	-13.37%	-51.99%	-58.74%	-35.94%
Net Income Growth	70.87%	23.13%	47.15%	15.26%	-86.73%	3.32%	4.86%	-29.18%	-56.71%	-41.45%
EPS Growth	76.23%	42.37%	60.80%	37.01%	-70.97%	4.84%	5.30%	-28.33%	-53.47%	-31.91%
Operating Cash Flow Growth	-1.20%	-50.94%	156.71%	-6.91%	-16.71%	-27.33%	-12.85%	-59.72%	-99.44%	-109.77%
Free Cash Flow Firm Growth	-9.27%	66.79%	121.03%	27.51%	-7.00%	-18.78%	-124.41%	-124.12%	-121.96%	-120.10%
Invested Capital Growth	21.23%	1.98%	-11.25%	8.53%	6.08%	16.51%	14.26%	12.93%	12.48%	12.03%
Revenue Q/Q Growth	-42.19%	33.86%	202.37%	158.70%	-224.57%	-36.51%	67.69%	-14.25%	14.16%	-1.78%
EBITDA Q/Q Growth	7.50%	-27.29%	40.83%	48.82%	-122.02%	-0.79%	15.80%	-23.15%	-19.28%	-0.33%
EBIT Q/Q Growth	7.31%	-29.42%	41.66%	49.64%	-123.82%	0.94%	15.99%	-18.72%	-15.97%	2.12%
NOPAT Q/Q Growth	3.65%	-24.33%	41.78%	49.61%	-123.68%	0.94%	14.94%	-16.31%	-17.26%	2.28%
Net Income Q/Q Growth	8.33%	-39.77%	49.28%	55.17%	-141.88%	3.90%	18.68%	1.21%	-25.23%	5.43%
EPS Q/Q Growth	7.35%	-38.78%	49.48%	63.40%	-124.58%	5.60%	18.83%	0.65%	-25.00%	6.06%
Operating Cash Flow Q/Q Growth	34.30%	-354.47%	151.59%	-17.33%	2.00%	4.40%	2.74%	-28.09%	-6.91%	15.27%
Free Cash Flow Firm Q/Q Growth	-219.32%	-269.63%	128.18%	28.40%	2.96%	-7.41%	2.86%	-5.67%	-7.73%	-122.07%
Invested Capital Q/Q Growth	10.82%	17.04%	-14.26%	6.82%	-10.97%	5.85%	6.05%	4.33%	1.35%	3.31%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	0.00%	100.00%	100.00%	100.00%	100.00%	100.00%
EBITDA Margin	-102.03%	-63.77%	-67.06%	-342.69%	0.00%	-220.52%	-138.90%	-276.62%	-192.61%	-184.34%
Operating Margin	-98.14%	-58.89%	-63.40%	-329.25%	0.00%	-213.58%	-136.88%	-269.85%	-198.94%	-193.67%
EBIT Margin	-98.48%	-61.43%	-63.53%	-329.25%	0.00%	-213.58%	-136.88%	-273.23%	-197.36%	-194.28%
Profit (Net Income) Margin	-76.18%	-48.05%	-46.01%	-274.31%	0.00%	-184.97%	-122.20%	-252.00%	-218.73%	-199.40%
Tax Burden Percent	99.34%	101.23%	100.57%	100.14%	101.04%	100.16%	101.52%	100.86%	119.80%	108.35%
Interest Burden Percent	77.87%	77.27%	72.02%	83.19%	92.62%	86.47%	87.94%	91.44%	92.51%	94.73%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-32.56%	-59.16%	-60.80%	-63.32%	-59.97%	-54.77%	-52.48%	-48.77%	-41.96%	-35.09%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	-21.65%	-8.89%	-5.02%	-19.66%	0.00%	-28.47%	-17.38%	-28.18%	-18.20%	-16.76%
Return on Assets (ROA)	-16.75%	-6.96%	-3.63%	-16.38%	0.00%	-24.66%	-15.52%	-25.99%	-20.17%	-17.20%
Return on Common Equity (ROCE)	-32.56%	-59.16%	-60.80%	-63.32%	-59.97%	-54.77%	-52.48%	-48.77%	-41.96%	-35.09%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-52.66%	-53.88%	-58.19%	0.00%	-64.61%	-64.19%	-58.90%	0.00%	-40.63%
Net Operating Profit after Tax (NOPAT)	-41	-42	-34	-58	-116	-52	-52	-61	-53	-45
NOPAT Margin	-68.70%	-41.22%	-44.38%	-230.47%	0.00%	-149.51%	-95.82%	-188.89%	-139.26%	-135.57%
Net Nonoperating Expense Percent (NNEP)	-0.38%	-0.66%	-0.11%	-0.96%	-3.16%	-1.08%	-1.20%	-1.60%	-2.21%	-1.49%
Return On Investment Capital (ROIC_SIMPLE)	-7.23%	-	-	-	-17.51%	-	-	-	-9.33%	-
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SG&A Expenses to Revenue	57.43%	74.02%	40.92%	96.05%	0.00%	65.32%	47.16%	76.62%	39.84%	60.24%
R&D to Revenue	140.71%	84.86%	122.48%	333.20%	0.00%	248.27%	189.72%	293.23%	259.10%	233.43%
Operating Expenses to Revenue	198.14%	158.89%	163.40%	429.25%	0.00%	313.58%	236.88%	369.85%	298.94%	293.67%
Earnings before Interest and Taxes (EBIT)	-58	-63	-49	-83	-165	-74	-75	-89	-75	-65
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-60	-65	-51	-87	-169	-76	-76	-90	-73	-61
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.35	2.89	3.04	3.73	3.43	2.30	2.86	2.85	3.22	3.81
Price to Tangible Book Value (P/TBV)	2.35	2.89	3.04	3.73	3.43	2.30	2.86	2.85	3.22	3.81
Price to Revenue (P/Rev)	5.00	10.50	19.52	31.86	28.85	6.59	8.38	10.59	13.86	18.67
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	1.06	3.54	6.30	15.39	12.73	0.30	1.78	2.38	4.65	8.61
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-1.89	-2.04	-2.15	-2.05	-2.02	-2.11	-2.11	-2.07	-2.03	-1.97
Leverage Ratio	1.96	2.13	2.22	2.13	2.10	2.22	2.20	2.16	2.12	2.04
Compound Leverage Factor	1.53	1.65	1.60	1.77	1.95	1.92	1.93	1.97	1.96	1.93
Debt to Total Capital	0.11%	0.10%	0.12%	0.11%	0.12%	0.22%	0.22%	0.20%	0.18%	0.16%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.04%	0.02%	0.02%	0.00%	0.00%
Long-Term Debt to Total Capital	0.11%	0.10%	0.12%	0.11%	0.12%	0.17%	0.19%	0.18%	0.18%	0.16%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	99.89%	99.90%	99.88%	99.89%	99.88%	99.78%	99.78%	99.80%	99.82%	99.84%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	3.94	3.01	3.21	2.88	3.08	3.19	3.48	3.96	4.89	5.94
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.01	-0.01
Net Debt to NOPAT	5.93	4.48	4.75	4.22	4.50	4.60	4.94	5.50	6.57	7.74
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.01	-0.01
Altman Z-Score	0.51	0.82	0.84	1.41	1.26	0.22	0.59	0.82	1.29	1.95
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.64	4.17	3.62	4.94	4.98	3.26	3.44	4.06	4.20	5.33
Quick Ratio	4.58	4.12	3.57	4.89	4.93	3.21	3.40	3.99	4.11	5.22
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-169	-53	31	-111	-155	-160	-149	-153	-145	-134
Operating Cash Flow to CapEx	-28,033.33%	-18,285.71%	7,185.71%	-97,500.00%	-83,100.00%	-7,709.09%	-14,783.33%	-8,290.91%	-6,472.73%	-3,027.27%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.22	0.14	0.08	0.06	0.06	0.13	0.13	0.10	0.09	0.09
Accounts Receivable Turnover	25.21	9.10	12.61	12.08	10.33	11.64	24.51	24.11	7.80	16.43
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	28.48	16.52	8.11	5.99	6.31	11.95	11.80	10.25	10.07	9.90
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Sales Outstanding (DSO)	14.48	40.10	28.95	30.20	35.34	31.35	14.89	15.14	46.81	22.22
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle (CCC)	14.48	40.10	28.95	30.20	35.34	31.35	14.89	15.14	46.81	22.22
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	-477	-535	-645	-564	-606	-546	-580	-617	-645	-654
Invested Capital Turnover	-0.49	-0.30	-0.15	-0.12	-0.13	-0.27	-0.25	-0.21	-0.19	-0.18
Increase / (Decrease) in Invested Capital	129	11	-65	53	39	108	96	92	92	89
Enterprise Value (EV)	278	570	588	1,097	999	47	282	327	611	1,092
Market Capitalization	1,317	1,691	1,822	2,271	2,265	1,050	1,325	1,455	1,821	2,367
Book Value per Share	$8.17	$8.54	$8.77	$8.50	$11.99	$8.55	$8.68	$9.59	$10.61	$11.68
Tangible Book Value per Share	$8.17	$8.54	$8.77	$8.50	$11.99	$8.55	$8.68	$9.59	$10.61	$11.68
Total Capital	562	587	601	610	661	458	465	512	566	623
Total Debt	0.60	0.60	0.70	0.70	0.80	1.00	1.00	1.00	1.00	1.00
Total Long-Term Debt	0.60	0.60	0.70	0.70	0.80	0.80	0.90	0.90	1.00	1.00
Net Debt	-1,039	-1,121	-1,234	-1,174	-1,266	-1,003	-1,043	-1,128	-1,210	-1,275
Capital Expenditures (CapEx)	0.30	0.70	0.70	0.10	0.10	1.10	0.60	1.10	1.10	2.20
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-202	-248	-325	-225	-243	-288	-294	-264	-266	-216
Debt-free Net Working Capital (DFNWC)	838	874	910	950	1,023	716	750	865	945	1,060
Net Working Capital (NWC)	838	874	910	950	1,023	716	750	865	945	1,060
Net Nonoperating Expense (NNE)	4.43	6.99	1.25	11	39	12	14	21	30	21
Net Nonoperating Obligations (NNO)	-1,039	-1,121	-1,245	-1,174	-1,266	-1,003	-1,043	-1,128	-1,210	-1,275
Total Depreciation and Amortization (D&A)	-2.10	-2.40	-2.70	-3.40	-4.00	-2.40	-1.10	-1.10	1.80	3.30
Debt-free, Cash-free Net Working Capital to Revenue	-76.65%	-153.94%	-348.02%	-315.99%	-310.06%	-180.63%	-186.21%	-191.85%	-202.21%	-170.43%
Debt-free Net Working Capital to Revenue	317.96%	542.27%	974.81%	1,331.70%	1,303.31%	448.84%	474.32%	629.84%	719.25%	836.04%
Net Working Capital to Revenue	317.96%	542.27%	974.81%	1,331.70%	1,303.31%	448.71%	474.26%	629.77%	719.25%	836.04%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.63)	($0.68)	($0.49)	($0.97)	($2.65)	($1.18)	($1.25)	($1.54)	($1.55)	($1.24)
Adjusted Weighted Average Basic Shares Outstanding	71.90M	72.10M	71.90M	71.70M	55.50M	54.10M	53.40M	53.30M	53.20M	53.20M
Adjusted Diluted Earnings per Share	($0.63)	($0.68)	($0.49)	($0.97)	($2.65)	($1.18)	($1.25)	($1.54)	($1.55)	($1.24)
Adjusted Weighted Average Diluted Shares Outstanding	71.90M	72.10M	71.90M	71.70M	55.50M	54.10M	53.40M	53.30M	53.20M	53.20M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	68.77M	68.71M	68.65M	68.43M	68.08M	55.03M	53.49M	53.40M	53.27M	53.23M
Normalized Net Operating Profit after Tax (NOPAT)	-41	-42	-34	-58	-116	-52	-52	-61	-53	-45
Normalized NOPAT Margin	-68.70%	-41.22%	-44.38%	-230.47%	0.00%	-149.51%	-95.82%	-188.89%	-139.26%	-135.57%
Pre Tax Income Margin	-76.69%	-47.46%	-45.75%	-273.91%	0.00%	-184.68%	-120.37%	-249.85%	-182.59%	-184.04%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-5.15%	0.00%	0.00%	-4.63%	-0.37%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Arvinas' Financials

When does Arvinas's fiscal year end?

According to the most recent income statement we have on file, Arvinas' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Arvinas' net income changed over the last 2 years?

Arvinas' net income appears to be on a downward trend, with a most recent value of -$198.90 million in 2024, falling from -$282.50 million in 2022. The previous period was -$367.30 million in 2023. View Arvinas' forecast to see where analysts expect Arvinas to go next.

What is Arvinas's operating income?

Arvinas's total operating income in 2024 was -$250.20 million, based on the following breakdown:

Total Gross Profit: $263.40 million
Total Operating Expenses: $513.60 million

How has Arvinas revenue changed over the last 2 years?

Over the last 2 years, Arvinas' total revenue changed from $131.40 million in 2022 to $263.40 million in 2024, a change of 100.5%.

How much debt does Arvinas have?

Arvinas' total liabilities were at $529.70 million at the end of 2024, a 17.8% decrease from 2023, and a 24.7% decrease since 2022.

How much cash does Arvinas have?

In the past 2 years, Arvinas' cash and equivalents has ranged from $81.30 million in 2022 to $311.70 million in 2023, and is currently $100.50 million as of their latest financial filing in 2024.

How has Arvinas' book value per share changed over the last 2 years?

Over the last 2 years, Arvinas' book value per share changed from 10.61 in 2022 to 8.17 in 2024, a change of -23.0%.

Related Companies

This page (NASDAQ:ARVN) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Arvinas (ARVN) Financials

Frequently Asked Questions About Arvinas' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Arvinas (ARVN) Financials

Annual Income Statements for Arvinas

Quarterly Income Statements for Arvinas

Annual Cash Flow Statements for Arvinas

Quarterly Cash Flow Statements for Arvinas

Annual Balance Sheets for Arvinas

Quarterly Balance Sheets for Arvinas

Annual Metrics And Ratios for Arvinas

Quarterly Metrics And Ratios for Arvinas

Frequently Asked Questions About Arvinas' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools